The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

Fintel reports that on December 22, 2025, Canaccord Genuity maintained coverage of 10x Genomics (NasdaqGS:TXG) with a Buy recommendation. Analyst Price Forecast Suggests 3.60% Upside As of December 21 ...

Spatial transcriptomics (ST) technologies reveal the spatial organization of gene expression in tissues, providing critical insights into development, neurobiology, and cancer. However, the high cost ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several analysts raised their price targets on the stock, pointing to a more optimistic outlook for the ...

The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical asset and returning to its drug discovery roots. The decision comes after ...